SCHEMBL4024685

SCHEMBL4024685

O=C1C=C(NNc2ccc(Br)cc2)CCC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 1/20 0.50
GAA P10253 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
POLB P06746 1/20 0.41
MAPT P10636 3/20 0.41
RAB9A P51151 1/20 0.41
IDO1 P14902 4/20 0.36
LMNA P02545 1/20 0.35
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 1/20 0.33
GFER P55789 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902804 0.83 MT-CO2 (0.50) MT-CO2GAASMN1; SMN2MEN1KMT2A
SCHEMBL6583074 0.82 POLB (0.56) MT-CO2GAASMN1; SMN2MEN1KMT2A
SCHEMBL17223076 0.69 CYP2A6 (0.57) GAASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL5225774 0.68 HTR2C (0.37) MT-CO2GAAMEN1KMT2AMAPT
SCHEMBL9275585 0.67 MT-CO2 (0.70) MT-CO2SMN1; SMN2MEN1KMT2APOLB
SCHEMBL31696451 0.66 SMARCA2 (0.41) MT-CO2GAASMN1; SMN2MEN1KMT2A
SCHEMBL2033213 0.66 MT-CO2 (0.69) MT-CO2GAASMN1; SMN2MEN1KMT2A
SCHEMBL1692082 0.65
SCHEMBL7866531 0.65
SCHEMBL16784518 0.64 MEN1 (0.73) MT-CO2GAASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009103022-A1 DERIVATIVES OF SUBSTITUTED FUSED RING CYCLOINDOLES AND METHODS OF THEIR USE ITHERX PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed
WO-2009103022-A1 DERIVATIVES OF SUBSTITUTED FUSED RING CYCLOINDOLES AND METHODS OF THEIR USE ITHERX PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed